COLLEEN WALSH, VP, Global Patient Safety Operations, Alnylam Pharmaceuticals

Colleen Walsh is Vice President, Global Safety Operations, at Alnylam. In her current role she oversees global case processing, affiliate and vendor management, quality and compliance, and process excellence for the Alnylam Global Patient Safety & Risk Management team.

She has worked in the field of pharmacovigilance for over 25 years, holding various leadership positions at companies such as Astra Zeneca, Alexion, Biogen, Vertex, and Alkermes.